Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive glucose monitoring and regulation in myocardial infarction
NL-OMON22714Active, not recruiting
- Sponsor
- Foreest Institute
- Start
- May 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of human insulin in myocardial infarction (MI) and acute coronary syndrome (ACS) (2 arms), sponsored by Foreest Institute. Started May 2008; status: active, not recruiting.
02
Drugs
human insulin
03
Conditions
myocardial infarction (MI)acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NL-OMON22714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON22714.